Related Experiment Video
Updated: Oct 7, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Sevoflurane inhalation conscious sedation for children having dental treatment
G Y Lahoud1, P A Averley, M R Hanlon
1Scarborough General Hospital, Scarborough YO12 6QL, UK. lahoud5@aol.com
Abstract:
An audit at the Queensway Anxiety Management Clinic of 2014 children, referred for dental treatment, showed that relative analgesia by inhalation of nitrous oxide and oxygen failed in 40% of cases successfully to complete treatment. We therefore investigated the efficacy of a new inhalation conscious sedation technique, which reduced the need for general anaesthesia. Seventy-five children aged 3-15 years were given inhalation conscious sedation, with sevoflurane 0.1-0.3% and nitrous oxide 40% in oxygen. In 69 children (92%), the dental treatment was completed successfully. Most children (93%) had recovered fully within 10 min without side-effects. Treatment was fully accepted by 88% of children and 91% of their parents. The use of sevoflurane in low concentrations to supplement nitrous oxide and oxygen for conscious sedation in children appears to be safe and effective and further study is currently in progress.
Related Concept Videos
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview
Stages of General Anesthesia
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

